Cabozantinib-[d4]

Ask supplier a question | View on supplier's website

Cabozantinib-[d4], is the labelled analogue of Cabozantinib. Cabozantinib is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET.

Supplier	BOC Sciences
Product #	BLP-002126
Pricing	Inquire
Molecular Weight	505.54
Molecular Formula	C28H20D4FN3O5

Feedback